Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-155 for Conjunctival Inflammation in Pterygium
NCT03521791Phase 4Completed
- Sponsor
- Laboratorios Sophia
- Start
- Dec 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of PRO-155 in pterygium, Conjunctival hyperemia, sponsored by Laboratorios Sophia. Started Dec 2017; status: completed.
02
Drugs
PRO-155
03
Conditions
pterygiumConjunctival hyperemia
Beyond the preview
Go deeper on NCT03521791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03521791.